Summary of NICE guidance for Multiple sclerosis

Karoline Brennan, Senior Medicines Information Pharmacist, North West Medicines Information CentreSource North West Medicines Information CentrePublished

Since this edition of NICE Bites was published, NICE has updated their guidance to replace the recommendation on using Sativex to treat spasticity in people with multiple sclerosis with a cross-reference to recommendations on THC:CBD spray in the NICE guideline on cannabis-based medicinal products (NICE NG144). A footnote was also amended to reflect a change in the law relating to gabapentin. Please go to NICE to check for any further updates to this guideline.

NICE Bites is a monthly bulletin from North West Medicines Information Centre which summarises key prescribing points from NICE guidance. NICE Bites No 72a, February 2015 includes one topic: Multiple sclerosis (NICE CG186). Sections covered  include diagnosis, treatment and management of MS symptoms.

(This website entry checked November 2020)